HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ghulam J Mufti Selected Research

Cyclosporine (Ciclosporin)

1/2022Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia.
6/2012Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party.
7/2009Imbalance of effector and regulatory CD4 T cells is associated with graft-versus-host disease after hematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab.
8/2007Delayed attainment of full donor chimaerism following alemtuzumab-based reduced-intensity conditioning haematopoeitic stem cell transplantation for acute myeloid leukaemia and myelodysplastic syndromes is associated with improved outcomes.
10/2002Allogeneic stem cell transplantation in the myelodysplastic syndromes: interim results of outcome following reduced-intensity conditioning compared with standard preparative regimens.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ghulam J Mufti Research Topics

Disease

49Myelodysplastic Syndromes (Myelodysplastic Syndrome)
11/2022 - 10/2002
23Neoplasms (Cancer)
01/2022 - 06/2002
13Aplastic Anemia (Anemia, Hypoplastic)
01/2022 - 08/2011
13Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2018 - 09/2004
10Graft vs Host Disease (Graft-Versus-Host Disease)
01/2020 - 10/2002
6Hematologic Neoplasms (Hematological Malignancy)
09/2021 - 02/2004
6Myeloid Leukemia (Leukemia, Myelocytic)
01/2021 - 05/2002
6Leukemia
11/2018 - 12/2005
5Disease Progression
05/2015 - 01/2006
4Infections
01/2020 - 07/2005
4Neutropenia
01/2019 - 11/2006
4Chromosomal Instability (Chromosome Stability)
09/2013 - 04/2002
3Lymphoproliferative Disorders (Lymphoproliferative Disorder)
10/2019 - 09/2002
3Bone Marrow Failure Disorders
01/2019 - 01/2009
3Multiple Myeloma
01/2018 - 07/2006
3Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
07/2014 - 04/2008
3Bronchiolitis Obliterans Syndrome
01/2014 - 08/2011
3Lymphoma (Lymphomas)
07/2012 - 07/2005
3Refractory Anemia with Excess of Blasts (RAEM)
12/2010 - 04/2010
2Anemia
12/2021 - 01/2020
2Diarrhea
01/2021 - 01/2020
2idiopathic Aplastic anemia
01/2020 - 01/2019
2Body Weight (Weight, Body)
01/2020 - 10/2017
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2019 - 01/2019
2Pemphigus (Pemphigus Vulgaris)
10/2019 - 09/2011
2Autoimmune Diseases (Autoimmune Disease)
05/2016 - 01/2016
2Mycoses (Diseases, Fungus)
01/2016 - 01/2015
2Thrombocytopenia (Thrombopenia)
06/2014 - 04/2014
2Budd-Chiari Syndrome (Budd Chiari Syndrome)
07/2012 - 06/2006
2Cytopenia
08/2010 - 04/2010
2Chromosome Aberrations (Chromosome Abnormalities)
05/2008 - 04/2002
2Testicular Neoplasms (Testicular Cancer)
10/2005 - 08/2005
1Thrombocytosis (Thrombocythemia)
01/2022
1Clostridium Infections
01/2021
1Asthenia
01/2020
1Nausea
01/2020
1Fatigue
01/2020
1Dizziness (Lightheadedness)
01/2020
1COVID-19
01/2020
1Paraproteinemias (Monoclonal Gammopathy)
10/2019
1Multiple Sclerosis
10/2019
1Viremia
10/2019
1Pruritus (Itching)
10/2019
1Lymphopenia (Lymphocytopenia)
01/2019
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2017
1Virus Diseases (Viral Diseases)
02/2017

Drug/Important Bio-Agent (IBA)

14Alemtuzumab (Campath)FDA Link
02/2017 - 09/2002
13Azacitidine (5 Azacytidine)FDA Link
10/2019 - 12/2005
7fludarabineIBA
11/2018 - 09/2004
6Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2021 - 12/2008
6Pharmaceutical PreparationsIBA
11/2019 - 12/2006
6Proteins (Proteins, Gene)FDA Link
10/2019 - 05/2002
6Lenalidomide (CC 5013)FDA Link
01/2016 - 05/2008
5Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2022 - 10/2002
5DNA (Deoxyribonucleic Acid)IBA
10/2019 - 04/2002
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2018 - 07/2006
4luspaterceptIBA
11/2022 - 01/2020
4AntigensIBA
02/2020 - 08/2005
4Rituximab (Mabthera)FDA Link
10/2019 - 01/2004
4Busulfan (Busulfex)FDA Link
11/2018 - 09/2004
4Cytarabine (Cytosar-U)FDA LinkGeneric
08/2010 - 04/2008
41,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
09/2007 - 04/2002
3eltrombopagFDA Link
01/2022 - 11/2014
3Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
01/2022 - 11/2013
3HematinicsIBA
01/2020 - 11/2014
3Imatinib Mesylate (Gleevec)FDA Link
10/2017 - 04/2003
3romiplostimFDA Link
11/2014 - 10/2009
2EpitopesIBA
02/2020 - 01/2015
2Antiviral Agents (Antivirals)IBA
01/2020 - 02/2017
2Chimeric Antigen ReceptorsIBA
11/2019 - 01/2019
2tisagenlecleucelIBA
11/2019 - 01/2019
2CytokinesIBA
01/2016 - 04/2009
2Thrombopoietin ReceptorsIBA
11/2014 - 10/2009
2Messenger RNA (mRNA)IBA
07/2013 - 06/2002
2Dexamethasone (Maxidex)FDA LinkGeneric
06/2012 - 08/2006
24-1BB Ligand (4 1BB Ligand)IBA
03/2009 - 03/2004
1treosulfanIBA
11/2021
1talazoparibIBA
09/2021
1Small Interfering RNA (siRNA)IBA
01/2021
1FidaxomicinIBA
01/2021
1HLA-A Antigens (HLA-A)IBA
02/2020
1Interleukin-2 (IL2)IBA
01/2020
1Acyclovir (Aciclovir)FDA LinkGeneric
01/2020
1RNA (Ribonucleic Acid)IBA
01/2020
1Epstein-barr virus BALF5 proteinIBA
10/2019
1Histamine Antagonists (Antihistamines)IBA
10/2019
1CladribineFDA LinkGeneric
10/2019
1Adenosine DeaminaseIBA
01/2019

Therapy/Procedure

24Therapeutics
01/2022 - 01/2004
19Hematopoietic Stem Cell Transplantation
01/2020 - 09/2002
19Stem Cell Transplantation
10/2019 - 10/2002
16Transplantation
11/2019 - 08/2006
9Drug Therapy (Chemotherapy)
11/2018 - 01/2006
6Homologous Transplantation
09/2012 - 09/2004
5Immunotherapy
11/2019 - 03/2004
3Erythrocyte Transfusion
12/2021 - 11/2014
3Cell Transplantation
11/2021 - 01/2019
2Platelet Transfusion (Blood Platelet Transfusions)
02/2020 - 06/2014
2Radiotherapy
01/2017 - 01/2011
2Liver Transplantation
07/2012 - 07/2005